Who Owns BBP?

Virtus Biotech ETF — Institutional Ownership & 13F Holdings

$84.64

+0.00 (+0.00%)

Market Cap

$34.8M

Shares Outstanding

407,474

Institutional Holders

12

Total Inst. Value

$5.4M

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

2

Closed Positions

2

Increased

5

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CWA Asset Management Group, LLC$1.5M24,801
2RAYMOND JAMES FINANCIAL INC$1.5M24,792
3CITADEL ADVISORS LLCNew$715K12,205
4MORGAN STANLEY$528K9,021
5ROYAL BANK OF CANADA$509K8,691
6LPL Financial LLC$276K4,713
7Cetera Investment Advisers$266K4,541
8JAG CAPITAL MANAGEMENT, LLC$212K3,625
9UBS Group AG$29K488
10Glen Eagle Advisors, LLC$3K50

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
ROYAL BANK OF CANADA-8K$509K
LPL Financial LLC-2K$276K
CWA Asset Management Group, LLC-656$1.5M

Related Stocks

Frequently Asked Questions

How many institutional investors hold BBP?

As of Q1 2025, 12 institutional investors report holding BBP (Virtus Biotech ETF) in their 13F filings.

Which hedge fund owns the most BBP?

The largest institutional holder of BBP is CWA Asset Management Group, LLC with $1.5M in shares.

Are institutions buying or selling BBP?

This quarter, 2 institutions opened new positions in BBP and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.